Related Experiment Video
Updated: Mar 23, 2026

06:55
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
15.5K
Weight loss after bariatric surgery: a propensity score analysis.
Neil Shah1, Jacob A Greenberg2, Glen Leverson3
1University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
The Journal of Surgical Research
|April 5, 2016
Summary
Laparoscopic sleeve gastrectomy and gastric bypass have similar complication rates. Lower BMI and no type 2 diabetes predict better weight loss after bariatric surgery.
Area of Science:
- Bariatric surgery outcomes
- Comparative effectiveness research
- Obesity treatment
Background:
- Laparoscopic sleeve gastrectomy (LSG) is now the most common bariatric procedure in the US.
- Predicting optimal outcomes for bariatric surgery remains a challenge.
- This study compares outcomes of LSG and laparoscopic Roux-en-Y gastric bypass (LRYGB) and identifies predictors of success.
Purpose of the Study:
- Compare 90-day and 1-year outcomes between LSG and LRYGB.
- Identify predictors of surgery type selection.
- Identify predictors of excess body weight loss (EBWL) greater than 50%.
Main Methods:
- Retrospective review of electronic health records for 270 LRYGB and 74 LSG patients (2010-2014).
- Propensity score adjustment used to control for patient characteristics.
- Multivariable analysis to identify predictors of EBWL >50%.
Main Results:
- Similar 90-day complication rates for LSG and LRYGB.
- LRYGB patients had more ED visits (27.1% vs 14.1%), but similar readmission rates.
- Lower BMI (OR 3.00), absence of type 2 diabetes (OR 2.55), and LRYGB (OR 5.29) predicted EBWL >50%.
Conclusions:
- LSG and LRYGB demonstrate comparable complication rates.
- Lower BMI and absence of type 2 diabetes are key predictors of significant weight loss.
- Preoperative patient counseling should incorporate these factors to set realistic expectations.
Related Concept Videos
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
363
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
363
Cancer Survival Analysis
820
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
820
Odds Ratio
2.2K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.2K
Drug Dosing: Obese Patients
334
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
334
Comparing the Survival Analysis of Two or More Groups
697
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
697

